Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases

American Journal of Surgical Pathology

Volumn 27, Issue 5, 2003, Pages 625-641

  Miettinen, Markku ^a   Kopczynski, Janusz ^a   Makhlouf, Hala R ^a   Sarlomo Rikala, Maarit ^b   Gyorffy, Hajnalka ^c   Burke, Allen ^a   Sobin, Leslie H ^a   Lasota, Jerzy ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Duodenum; Genetics; GIST; Immunohistochemistry; KIT; Leiomyoma; Leiomyosarcoma; Pathology

Indexed keywords

ALPHA ACTIN; CD34 ANTIGEN; DESMIN; PROTEIN S 100; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARMY; ARTICLE; BONE METASTASIS; CANCER GENETICS; CANCER RECURRENCE; DUODENUM CANCER; ESOPHAGUS; EXON; FEMALE; FINLAND; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROFIBROMATOSIS; ONCOGENE C KIT; PERITONEAL CAVITY; PREDICTION; PROTEIN EXPRESSION; RETROPERITONEUM; SCHOOL CHILD; SPINDLE CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DUODENAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEIOMYOMA; LEIOMYOSARCOMA; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; STROMAL CELLS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037407876     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200305000-00006     Document Type: Article

References (24)

1. Ashley SW, Wells SA. Tumors of the small intestine. Semin Oncol 1988;15:116-28.
2. Daimaru Y, Kido H, Hashimoto H, et al. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol 1988;19:257-64.
3. Dematteo RP, Heinrich MC, El-Rifai WM, et al. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 2002;33:466-77.
4. Demetri G, van Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.
5. Goldblum JR, Appelman HD. Stromal tumors of duodenum: a histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 1995;19:71-80.
6. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577-80.
7. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-69.
8. Kindblom LG, Remotti HE, Angervall L, et al. Gastrointestinal pacemaker cell tumor: a manifestation of neurofibromatosis 1 [Abstract]. Mod Pathol 1999;12:77.
9. Kitamura Y, Hirota S, Nishida T. Molecular pathology of c-kit proto-oncogene and development of gastrointestinal stromal tumors. Ann Chir Gynaecol 1998;87:282-6.
10. Lasota J, Jasinski M, Sarlomo-Rikala M, et al. C-kit mutations occur preferentially in malignant vs benign GISTs and do not occur in leiomyomas and leiomyosarcomas. Am J Pathol 1999;154: 53-60.
11. Lasota J, Wozniak A, Sarlomo-Rikala M, et al. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors: a study of two hundred cases. Am J Pathol 2000;157: 1091-5.
12. Lux M, Rubin BP, Biase TL, et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 2000;156:791-5.
13. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Esophageal stromal tumors: a clinicopathologic, immunohistochemical and molecular genetic study of seventeen cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000;24:211-22.
14. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs of different locations and their differential diagnosis. Mod Pathol 2000;13:536-41.
15. Miettinen M, Sarlomo-Rikala M, Lasota J. KIT expression in angiosarcomas and in fetal endothelial cells: lack of c-kit mutations in exons 11 and 17 in angiosarcoma. Mod Pathol 2000;13:536-41.
16. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1-12.
17. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Gastrointestinal stromal tumors of the rectum: a clinicopathologic, immunohistochemical and molecular genetic study of 144 cases. Am J Surg Pathol 2001;25:1121-33.
18. Min K-W. Small intestinal stromal tumors with skeinoid fibers: clinicopathological, immunohistochemical, and ultrastructural investigations. Am J Surg Pathol 1992;16:145-55.
19. Moskaluk CR, Tian Q, Marshall CR, et al. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene 1999;18:1897-902.
20. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001;61: 8118-21.
21. Solomons NW, Wagonfeld JB, Thomsen S, et al. Leiomyosarcoma of the duodenum in a 10-year-old boy. Pediatrics 1976;58:268-73.
22. Taniguchi M, Nishida T, Hirota S, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999;59: 4297-300.
23. Tuveson DA, Fletcher JA. Signal transduction pathways in sarcoma as targets for therapeutic intervention. Curr Opin Oncol 2001;13:249-55.
24. Ueyama T, Guo K-J, Hashimoto H, et al. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69:947-55.